Atike Gökçen Demiray

10PUBLICATIONS
93CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Clinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 13, 2026
Prognostic Value of Systemic Inflammatory Markers in Locally Advanced or Metastatic Melanoma: A Real-World Analysis.

Burçin Çakan Demirel, Semra Taş, Taliha Güçlü Kantar

|Dec 30, 2025
Real-World Outcomes of Treatment Approaches and the Impact of Systemic Inflammation Markers on Survival in Patients with Locally Advanced and Metastatic Laryngeal Cancer.

Burçin Çakan Demirel, Semra Taş, Taliha Güçlü Kantar

|Nov 27, 2025
Lymphocyte-Associated Inflammation Markers Predict Bleomycin-Induced Pulmonary Toxicity in Testicular Cancer.

Melek Özdemir, Gamze Gököz Doğu, Burcu Yapar Taşköylü

|Nov 27, 2025
Sarcopenic Obesity and Sarcopenic Visceral Obesity, Calculated Using the Skeletal Muscle İndex and Visceral Fat İndex at the L3 Vertebra Level, Do Not Predict Survival Rates in Endometrial Cancer Patients.

Melek Özdemir, Gamze Gököz Doğu, Burcu Yapar Taşköylü

|Feb 24, 2025
Characterization of lncRNAs contributing to drug resistance in epithelial ovarian cancer.

Ehteram Khademi Siahestalkhi, Aydin Demiray, Arzu Yaren

|Sep 26, 2022
The Effect of Continuing Chemotherapy after Chemoradiotherapy during the Time to Surgery on Tumor Response and Survival for Local Advanced Rectal Cancer.

Atike Gökçen Demiray, Arzu Yaren, Uğur Sungurtekin

Pageof 2

Frequent Collaborators

6 joint publications

Serkan Değirmencioğlu

5 joint publications

Gamze Gököz Doğu

5 joint publications

Melek Özdemir

5 joint publications

Arzu Yaren